Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Larsson

Showing results (141-150 of 153) with videos related to

Pageof 16
Sort By:
Glycobiology|June 6, 1998
The lactosylceramide binding specificity of Helicobacter pyloriJ Angström, S Teneberg, M A Milh, et al.
The Journal of Biological Chemistry|September 29, 2000
Salivary agglutinin, which binds Streptococcus mutans and Helicobacter pylori, is the lung scavenger receptor cysteine-rich protein gp-340A Prakobphol, F Xu, V M Hoang, et al.
Environmental Microbiology|March 28, 2013
Characterization of water and wildlife strains as a subgroup of Campylobacter jejuni using DNA microarraysRichard A Stabler, Jonas T Larsson, Suaad Al-Jaberi, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
Pharmacogenomic synthetic lethal screens reveal hidden vulnerabilities and new therapeutic approaches for treatment of NF1-associated tumorsKyle B Williams, Alex T Larsson, Bryant J Keller, et al.
Molecular Cancer Therapeutics|October 2, 2025
Pharmacogenomic synthetic lethal screens reveal hidden vulnerabilities and new therapeutic approaches for treatment of NF1-associated tumorsKyle B Williams, Alex T Larsson, Bryant J Keller, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon restoration of RB function in malignant peripheral nerve sheath tumorsJiawan Wang, Ana Calizo, Lindy Zhang, et al.
Science Advances|November 24, 2023
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumorsJiawan Wang, Ana Calizo, Lindy Zhang, et al.
Human Mutation|January 1, 1997
Frequency of RET mutations in long- and short-segment Hirschsprung diseaseM Seri, L Yin, V Barone, et al.
Bone|April 7, 2020
PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcomaBranden A Smeester, Nicholas J Slipek, Emily J Pomeroy, et al.
Molecular Cancer Therapeutics|October 1, 2020
Implication of <i>ZNF217</i> in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K-AKT Signaling for the Treatment of Metastatic OsteosarcomaBranden A Smeester, Garrett M Draper, Nicholas J Slipek, et al.
Pageof 16

Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
Glycobiology|June 6, 1998
The lactosylceramide binding specificity of Helicobacter pyloriJ Angström, S Teneberg, M A Milh, et al.
The Journal of Biological Chemistry|September 29, 2000
Salivary agglutinin, which binds Streptococcus mutans and Helicobacter pylori, is the lung scavenger receptor cysteine-rich protein gp-340A Prakobphol, F Xu, V M Hoang, et al.
Environmental Microbiology|March 28, 2013
Characterization of water and wildlife strains as a subgroup of Campylobacter jejuni using DNA microarraysRichard A Stabler, Jonas T Larsson, Suaad Al-Jaberi, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
Pharmacogenomic synthetic lethal screens reveal hidden vulnerabilities and new therapeutic approaches for treatment of NF1-associated tumorsKyle B Williams, Alex T Larsson, Bryant J Keller, et al.
Molecular Cancer Therapeutics|October 2, 2025
Pharmacogenomic synthetic lethal screens reveal hidden vulnerabilities and new therapeutic approaches for treatment of NF1-associated tumorsKyle B Williams, Alex T Larsson, Bryant J Keller, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon restoration of RB function in malignant peripheral nerve sheath tumorsJiawan Wang, Ana Calizo, Lindy Zhang, et al.
Science Advances|November 24, 2023
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumorsJiawan Wang, Ana Calizo, Lindy Zhang, et al.
Human Mutation|January 1, 1997
Frequency of RET mutations in long- and short-segment Hirschsprung diseaseM Seri, L Yin, V Barone, et al.
Bone|April 7, 2020
PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcomaBranden A Smeester, Nicholas J Slipek, Emily J Pomeroy, et al.
Molecular Cancer Therapeutics|October 1, 2020
Implication of <i>ZNF217</i> in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K-AKT Signaling for the Treatment of Metastatic OsteosarcomaBranden A Smeester, Garrett M Draper, Nicholas J Slipek, et al.
Pageof 16